US 11697648
Fused pyrimidine pyridinone compounds as JAK inhibitors
granted A61KA61K45/06A61P
Quick answer
US patent 11697648 (Fused pyrimidine pyridinone compounds as JAK inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K45/06, A61P, A61P35/00